-+ 0.00%
-+ 0.00%
-+ 0.00%

Virax Biolabs closes exercise of preferred investment options at USD 6, raises USD 3.3 million

PUBT·07/10/2026 20:05:54
Listen to the news
Virax Biolabs closes exercise of preferred investment options at USD 6, raises USD 3.3 million
  • Virax Biolabs closed the cash exercise of preferred investment options for 548,000 ordinary shares at USD 6 per share, raising about USD 3.3 million gross.
  • The preferred investment options had an original exercise price of USD 10 per share.
  • Issued new unregistered Series A preferred investment options for 548,000 shares, issued new unregistered Series B preferred investment options for 1,096,000 shares.
  • New warrants carry a USD 6 exercise price, become exercisable following shareholder approval of an authorized share increase.
  • Net proceeds earmarked for working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Virax Biolabs Group Ltd. published the original content used to generate this news brief on July 10, 2026, and is solely responsible for the information contained therein.